Transforming Clinical Trials at Mass General Brigham with HIRO
At Mass General Brigham, we’re redefining clinical trial management with HIRO, using a cutting-edge approach to optimizing trial feasibility, site selection, and patient enrollment. At SCOPE 2025, Christopher Herrick, HIRO Vice President, MGB, reviewed collaboration with some of our industry partners and highlighted how strategic partnerships and innovative methodologies are driving efficiency, accelerating study start-up, and improving patient recruitment.
These are some of the highlights of the HIRO approach:
Sponsor Collaboration and Standardized Feasibility Process:
Starts with a clear, standardized process using our Sponsor Inquiry Intake form and site feasibility questionnaire. This streamlined approach ensures efficient study evaluation and PI matching, setting the stage for study success.
Site & PI Selection Powered by Data:
Uses data-driven insights to determine and evaluate if our sites and patient cohorts are the right fit for the study, determining if the current patient population can meet study needs. Our team selects PI’s by identifying Investigators in the Mass General Brigham network with the expertise and motivation to lead a clinical trial.
Optimized Study Start-Up:
Our comprehensive, step-by-step guide ensures we stay on track with critical milestones, turning what was once a passive system into an actively managed process. With centralized oversight and parallel workflows across multiple sites, we seamlessly coordinate activities between sponsors, site teams, IRBs, and legal departments for smoother, faster trials.
Regulatory & Contracting Acceleration:
By leveraging project management tools and managing stakeholder communications, we minimize delays caused by errors and discrepancies. Lessons learned from past studies are applied to ensure continuous improvements. By directly overseeing the completion of regulatory forms, IRB submissions, and budget support we are able to expedite site startup.
Patient Recruitment & Enrollment Monitoring:
HIRO supports study sites with pre-screening activities, providing customized, study criteria-based lists of eligible patients to streamline recruitment. The HIRO team helps assess and troubleshoot recruitment strategies and processes to optimize patient enrollment. We maintain close collaboration with clinical trial teams through monthly check-ins, data-driven insights and customized recruitment strategies to ensure continuous improvement and enrollment success.
Link to the full Clinical Trial Vanguard article: https://lnkd.in/eti73aMV
Image generated using AI
#Scope2025 #ClinicalTrials #ResearchInnovation #HealthcareTransformation Tom Arneman, Ye Chin Lee, MBA, Conor Sean O'Brien